RT Journal Article
SR Electronic
T1 Clinical activity of durvalumab for patients with advanced mismatch repair-deficient and repair-proficient endometrial cancer. A nonrandomized phase 2 clinical trial
JF Journal for ImmunoTherapy of Cancer
JO J Immunother Cancer
FD BMJ Publishing Group Ltd
SP e002255
DO 10.1136/jitc-2020-002255
VO 9
IS 6
A1 Antill, Yoland
A1 Kok, Peey-Sei
A1 Robledo, Kristy
A1 Yip, Sonia
A1 Cummins, Michelle
A1 Smith, Deborah
A1 Spurdle, Amanda
A1 Barnes, Elizabeth
A1 Lee, Yeh Chen
A1 Friedlander, Michael
A1 Baron-Hay, Sally
A1 Shannon, Catherine
A1 Coward, Jermaine
A1 Beale, Philip
A1 Goss, Geraldine
A1 Meniawy, Tarek
A1 Lombard, Janine
A1 Andrews, John
A1 Stockler, Martin R
A1 Mileshkin, Linda
A1 
YR 2021
UL http://jitc.bmj.com/content/9/6/e002255.abstract
AB Markup server — Error Not Found The page you were trying to reach could not be found. Please check the address for the page you were trying to reach. If you believe you have reached this page in error, you may contact us with any questions.